image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

SigmaRoc - Prospective PE for next year drops to just 7.2

November 2024

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • SRC
  • Price:
  • 67.5p
Well-flagged by last month’s update, SigmaRoc’s interims unveiled EBITDA jumping from £55m to £100m, largely reflecting the first time contribution from CRH’s limestone and lime assets. Synergies from that have grown by €2m to €35m “with further progress to be made following the completion of Deal 3 (Poland).” The transformative deal has presented SigmaRoc with leadership in five European countries and number two in another three and as Panmure Liberum says, “Many of these markets enjoy defensive characteristics with infrastructure, agriculture, food producers and water purification strong, offset by sluggish residential new build”. The broker forecasts pretax profit to increase from £71.2m to £123m this year, £146m next an ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author

LIMTED TIME OFFER

SUBSCRIBE TODAY AND SAVE £30 USING OFFER CODE 30OFFTMI

To access our archive of articles and receive current issues you need to subscribe